On November 18, 2021, a mitral valve seal surgery using MitraClip (without opening the chest) and CarnaLife Holo took place. The procedure was performed at the University Clinical Hospital in Opole, by a team led by dr. hab. n. med. Jerzy Sacha.
Three-dimensional visualization of imaging diagnostic data of the heart was used in planning and throughout the procedure. As the sterility of the room was not compromised, physicians were able to use the CarnaLife Holo technology unobstructed throughout the procedure and observe the injection sites closely.
“With the unique CarnaLife Holo technology, developed by the Polish company MedApp, we obtained holographic images of the inside of the heart, which were used during the MitraClip valve repair procedure without opening the chest,” explains cardiologist dr. hab. med. Jerzy Sacha and adds: “I can say that the technology of 3D visualization of diagnostic data is the future. We should all give it a try and invest in holography experience.
The surgery was conducted by a team consisting of:
dr hab. n. med. Jerzy Sacha
Dr Krzysztof Krawczyk (cardiologist)
Dr Jaroslaw Bugajski (cardiologist)
Mateusz Stanisz (anesthesiologist)
Monika Świderska (assistant)
Małgorzata Werner (assistant)
Danuta Radiszewska (anesthesiology nurse)
Filip Zuczek (x-ray technician).
Technological assistance was provided by Jakub Kasprzak and Kacper Pabianek from MedApp, Tomasz Ogonowski from GE and Szymon Dziedzic (Abbott).
Read more See similar articles:
We are looking for companies and individuals interested in distributing MedApp’s medical technology.
CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. With the help of Microsoft’s HoloLens 2, the physician can see in real space a three-dimensional hologram reflecting the structure of the imaged anatomical area.
MedApp after Q2 2022: Another Quarter of Geographic and Product Expansion
MedApp, a publicly listed company in the innovative medical technology industry, recorded net sales of PLN 1,588 million, PLN 878 thousand EBITDA earnings and PLN 405 thousand net profit in the second quarter of 2022, despite the increasing uncertainty in the business environment and the challenges facing medical facilities.
MedApp is the laureate of the Special Award of PARP and NCBR
During the Gala of the 24th edition of the Polish Product of the Future competition, we received a special award from the Polish Agency for Enterprise Development and the National Center for Research and Development!